Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ohashi

Showing results (41-50 of 550) with videos related to

Pageof 55
Sort By:
Immunity|April 13, 2022
DC1s shield Tpex cells to bolster PD-1 blockadeDavid G Brooks, Pamela S Ohashi
Science (New York, N.Y.)|April 1, 2017
Costimulation, a surprising connection for immunotherapyDerek L Clouthier, Pamela S Ohashi
Journal of Oral Rehabilitation|April 20, 2004
Antibacterial activity of silver inorganic agent YDA fillerS Ohashi, S Saku, K Yamamoto
Horumon to Rinsho. Clinical Endocrinology|February 1, 1978
[Somatostatin. Radioimmunoassay of somatostatin using Tyr8-somatostatin as a leveled antigen and the characteristics of the method]S Sawano, T Kokubu, S Ohashi
European Journal of Immunology|February 27, 2014
Mir-155, a central modulator of T-cell responsesEvan F Lind, Pamela S Ohashi
Cellular and Molecular Life Sciences : CMLS|May 12, 1998
Activation of cytotoxic T cells by solid tumours?D E Speiser, P S Ohashi
Nature Reviews. Immunology|December 24, 2014
Clinical blockade of PD1 and LAG3--potential mechanisms of actionLinh T Nguyen, Pamela S Ohashi
Scandinavian Journal of Gastroenterology|November 1, 1989
Endoscopic ultrasonography in the assessment of invasive gastric cancerS Ohashi, S Nakazawa, J Yoshino
Current Opinion in Immunology|November 5, 2002
Making and breaking tolerancePamela S Ohashi, Anthony L DeFranco
Current Oncology (Toronto, Ont.)|May 6, 2020
Targeting T cell activation in immuno-oncologyS D Saibil, P S Ohashi
Pageof 55

Showing results (41-50 of 550) with videos related to

Sort By:
Pageof 55
Immunity|April 13, 2022
DC1s shield Tpex cells to bolster PD-1 blockadeDavid G Brooks, Pamela S Ohashi
Science (New York, N.Y.)|April 1, 2017
Costimulation, a surprising connection for immunotherapyDerek L Clouthier, Pamela S Ohashi
Journal of Oral Rehabilitation|April 20, 2004
Antibacterial activity of silver inorganic agent YDA fillerS Ohashi, S Saku, K Yamamoto
Horumon to Rinsho. Clinical Endocrinology|February 1, 1978
[Somatostatin. Radioimmunoassay of somatostatin using Tyr8-somatostatin as a leveled antigen and the characteristics of the method]S Sawano, T Kokubu, S Ohashi
European Journal of Immunology|February 27, 2014
Mir-155, a central modulator of T-cell responsesEvan F Lind, Pamela S Ohashi
Cellular and Molecular Life Sciences : CMLS|May 12, 1998
Activation of cytotoxic T cells by solid tumours?D E Speiser, P S Ohashi
Nature Reviews. Immunology|December 24, 2014
Clinical blockade of PD1 and LAG3--potential mechanisms of actionLinh T Nguyen, Pamela S Ohashi
Scandinavian Journal of Gastroenterology|November 1, 1989
Endoscopic ultrasonography in the assessment of invasive gastric cancerS Ohashi, S Nakazawa, J Yoshino
Current Opinion in Immunology|November 5, 2002
Making and breaking tolerancePamela S Ohashi, Anthony L DeFranco
Current Oncology (Toronto, Ont.)|May 6, 2020
Targeting T cell activation in immuno-oncologyS D Saibil, P S Ohashi
Pageof 55